Intravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndrome
about
Ranibizumab for the treatment of degenerative ocular conditions.Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization.Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach.An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
P2860
Intravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndrome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravitreal ranibizumab in ch ...... iditis and panuveitis syndrome
@en
Intravitreal ranibizumab in ch ...... ditis and panuveitis syndrome.
@nl
type
label
Intravitreal ranibizumab in ch ...... iditis and panuveitis syndrome
@en
Intravitreal ranibizumab in ch ...... ditis and panuveitis syndrome.
@nl
prefLabel
Intravitreal ranibizumab in ch ...... iditis and panuveitis syndrome
@en
Intravitreal ranibizumab in ch ...... ditis and panuveitis syndrome.
@nl
P2093
P2860
P356
P1433
P1476
Intravitreal ranibizumab in ch ...... iditis and panuveitis syndrome
@en
P2093
Doukas Dardabounis
Efstratios Alvanos
Georgios D Panos
Zisis Gatzioufas
P2860
P356
10.1136/BCR-2013-009572
P577
2013-07-17T00:00:00Z